Type A botulinum toxin in the upper aspect of the face
Authors:
- Dóris HexselDHDóris Hexsel
- Taciana Dal'FOrnoTDTaciana Dal'FOrno
- 1 November 2003
- journal article
- review article
- Published by Elsevier in Clinics in Dermatology
- Vol. 21 (6) , 488-497
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Bilateral, double-blind, randomized comparison of 3 doses of botulinum toxin type A and placebo in patients with crow's feetJournal of the American Academy of Dermatology, 2002
- Botulinum-A Toxin Treatment of the Lower Eyelid Improves Infraorbital Rhytides and Widens the EyeDermatologic Surgery, 2001
- Practical aspects of using botulinum toxin type BEuropean Journal of Neurology, 2001
- Botox in dermatologyInternational Journal of Dermatology, 2001
- The clinical profile of elan pharmaceuticals' botulinum toxin type BEuropean Journal of Neurology, 2001
- Special Feature: BOTOX treatment for expressive facial lines and wrinklesCurrent Opinion in Otolaryngology & Head and Neck Surgery, 2000
- The cosmetic uses of Botulinum toxin type AInternational Journal of Dermatology, 1999
- DYSBOT: A single‐blind, randomized parallel study to determine whether any differences can be detected in the efficacy and tolerability of two formulations of botulinum toxin type A—Dysport and Botox—assuming a ratio of 4:1Movement Disorders, 1997
- Botulinum A exotoxin for glabellar folds: A double-blind, placebo-controlled study with an electromyographic injection techniqueJournal of the American Academy of Dermatology, 1996
- Botulinum A exotoxin use in clinical dermatologyJournal of the American Academy of Dermatology, 1996